New Creatinine- and Cystatin C–Based Equations to Estimate GFR without Race | NEJM
ckd-epi.gif
Comparison of creatinine clearance with GFR estimated b | Open-i
The New GFR Equations — NephJC
Performance of the estimated glomerular filtration rate creatinine and | IJNRD
CKD-EPI creatinine/cystatin equation example - YouTube
Comparison of five glomerular filtration rate estimating equations as predictors of acute kidney injury after cardiovascular surgery | Scientific Reports
Creatinine Clearance Calculator | Cockcroft-Gault Equation | Stages of AKI
How to calculate gfr from creatinine clearance - The Tech Edvocate
Clarifying the confusion of GFRs, creatinine, and cystatin C
Frontiers | The Glomerular Filtration Rate: From the Diagnosis of Kidney Function to a Public Health Tool
Creatinine Clearance Calculator | Cockcroft-Gault Equation | Stages of AKI
Performance of Cockcroft-Gault, MDRD, and CKD-EPI in estimating prevalence of renal function and predicting survival in the oldest old | BMC Geriatrics | Full Text
Renal Pharmacy Group Beginners Lectures ppt download
Implementation of the 2021 CKD-EPI GFR equations
Cystatin C Based Equations - CKD-EPI
CKD-EPI formula for Caucasian population based on creatinine... | Download Table
Estimating Glomerular Filtration Rate - NIDDK
Prevalence of Augmented Renal Clearance and Performance of Glomerular Filtration Estimates in Indigenous Australian Patients Requiring Intensive Care Admission | Semantic Scholar
Performance of the 2021 Race-Free CKD-EPI Creatinine- and Cystatin C–Based Estimated GFR Equations Among Kidney Transplant Recipients - ScienceDirect
Race and eGFR: Addressing Health Disparities in Chronic Kidney Disease
Creatinine Based Equations - CKD-EPI
CKD Epi Formula in an excel formula - Microsoft Community Hub
CKD-EPI is the most reliable equation to estimate renal function in patients with systemic lupus erythematosus | Nefrología
The New GFR Equations — NephJC
JCM | Free Full-Text | Should We Continue Assessing Glomerular Filtration Rate with the Cockroft–Gault Formula in NOAC-Treated Patients? The Magnitude of the Problem